08:00 , Feb 9, 2015 |  BC Week In Review  |  Financial News

AuraSense financial update

AuraSense Therapeutics LLC , Skokie, Ill.   Business: Autoimmune, Cancer, Dermatology   Date announced: 2015-02-04   Note: AuraSense raised an undisclosed amount in a second close of a series C round, bringing the total raised...
07:00 , Jul 28, 2014 |  BC Week In Review  |  Company News

AuraSense management update

AuraSense Therapeutics LLC , Skokie, Ill.   Business: Genomics   Hired: David Snyder as CFO, formerly EVP and CFO of Cellular Dynamics International Inc.  ...
07:00 , Jun 23, 2014 |  BC Week In Review  |  Financial News

AuraSense completes venture financing

AuraSense Therapeutics LLC , Skokie, Ill.   Business: Genomics   Date completed: 2014-06-17   Type: Venture financing   Raised: $13.6 million   Investors: William Gates III; Rathmann Family Foundation; Individual investors  ...
00:50 , Jun 18, 2014 |  BC Extra  |  Financial News

AuraSense raises $13.6 million in series C

AuraSense Therapeutics LLC (Skokie, Ill.) raised $13.6 million in a series C round. The company is developing therapies based on its Spherical Nucleic Acid constructs, which are nanoscale particles that consist of a spherical arrangement...
07:00 , Aug 5, 2013 |  BC Week In Review  |  Financial News

AuraSense financial update

AuraSense raised an undisclosed amount in the second tranche of a series B round. The company raised an undisclosed amount in the round in December 2011. Investors in the round include AbbVie Inc. and individual...
07:00 , Jul 26, 2012 |  BC Innovations  |  Distillery Techniques

Technology: Drug platforms

Approach Summary Licensing status Publication and contact information Drug platforms Topical delivery of small interfering RNA with spherical nucleic acid-nanoparticle conjugates Spherical nucleic acid-nanoparticle conjugates could be useful for topical delivery of siRNA to skin...
07:00 , May 28, 2012 |  BioCentury  |  Finance

AbbVie earlier

AbbVie earlier Early stage investor Abbott Biotech Ventures will start investing even earlier after parent company Abbott Laboratories (NYSE:ABT) splits in two, the firm's head of venture investment, Steven Kuemmerle, said at last week's C21...
08:00 , Feb 6, 2012 |  BC Week In Review  |  Financial News

AuraSense completes venture financing

AuraSense Therapeutics LLC , Evanston, Ill.   Business: Genomics   Date completed: 1/31/12   Type: Venture financing   Raised: $575,000   Investor: Invest Illinois Venture Fund  ...
08:00 , Jan 2, 2012 |  BC Week In Review  |  Financial News

AuraSense completes venture financing

AuraSense Therapeutics LLC , Evanston, Ill.   Business: Genomics   Date completed: 12/22/11   Type: Venture financing   Raised: Not disclosed   Investors: Abbott Biotech Ventures; individual investors  ...
01:35 , Dec 23, 2011 |  BC Extra  |  Financial News

AuraSense closes series B round

Gene therapy company AuraSense Therapeutics LLC (Evanston, Ill.) raised an undisclosed amount in a series B round. Investors included Abbott Laboratories (NYSE:ABT) subsidiary Abbott Biotech Ventures; Patrick Ryan, founder of Aon Corp. (NYSE:AON); David Walt,...